SCHEMBL23748078

SCHEMBL23748078

CCSc1c(-c2nc3cc(C(F)(F)C(F)(F)F)ncc3n2C)ncn1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30080318 1.00 — —
SCHEMBL23748057 0.84 — —
SCHEMBL30080303 0.84 — —
SCHEMBL23748059 0.83 — —
SCHEMBL30080336 0.82 — —
Hydrochloric Acid SCHEMBL30080589 0.80 — —
SCHEMBL24701891 0.79 MEN1 (0.35) —
SCHEMBL25658526 0.78 POLB (0.30) —
SCHEMBL18819419 0.78 NPC1 (0.32) —
SCHEMBL21727260 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220009930-A1 PROCESS FOR PREPARING IMIDAZOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2022-01-13 — — US disclosed
EP-3864016-A1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-08-18 — — EP disclosed
EP-3864015-A1 PROCESS FOR PREPARING IMIDAZOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-08-18 — — EP disclosed
Send feedback